Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Sablerolles, Roos S GRietdijk, Wim J R
Goorhuis, Abraham
Postma, Douwe F
Visser, Leo G
Schmitz, Katharina S
Geers, Daryl
Bogers, Susanne
van Haren, Eva
Koopmans, Marion P G
Dalm, Virgil A S H
Kootstra, Neeltje A
Huckriede, Anke L W
Akkerman, Renate
Beukema, Martin
Lafeber, Melvin
van Baarle, Debbie
de Vries, Rory D
van der Kuy, P Hugo M
GeurtsvanKessel, Corine H
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers.Published in
Clinical infectious diseases 2022 Online ahead of printPMID
35723273ae974a485f413a2113503eed53cd6c53
10.1093/cid/ciac495
Scopus Count
Collections
Related articles
- A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaques.
- Authors: He X, Aid M, Chandrashekar A, Yu J, McMahan K, Wegmann F, Jacob-Dolan C, Maron JS, Atyeo C, Wan H, Sellers D, Liu J, Lifton M, Gardner S, Bondzie EA, Barrett J, Ahmad K, Anioke T, Yalley-Ogunro J, Muench J, Goode A, Andersen H, Lewis MG, Alter G, Schuitemaker H, Zahn R, Barouch DH
- Issue date: 2022 Mar 30
- Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination.
- Authors: Geers D, Sablerolles RSG, van Baarle D, Kootstra NA, Rietdijk WJR, Schmitz KS, Gommers L, Bogers S, Nieuwkoop NJ, van Dijk LLA, van Haren E, Lafeber M, Dalm VASH, Goorhuis A, Postma DF, Visser LG, Huckriede ALW, Sette A, Grifoni A, de Swart RL, Koopmans MPG, van der Kuy PHM, GeurtsvanKessel CH, de Vries RD, SWITCH research group
- Issue date: 2023 Jan 20
- Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
- Authors: Costa Clemens SA, Weckx L, Clemens R, Almeida Mendes AV, Ramos Souza A, Silveira MBV, da Guarda SNF, de Nobrega MM, de Moraes Pinto MI, Gonzalez IGS, Salvador N, Franco MM, de Avila Mendonça RN, Queiroz Oliveira IS, de Freitas Souza BS, Fraga M, Aley P, Bibi S, Cantrell L, Dejnirattisai W, Liu X, Mongkolsapaya J, Supasa P, Screaton GR, Lambe T, Voysey M, Pollard AJ, RHH-001 study team
- Issue date: 2022 Feb 5
- Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN.
- Authors: Yu J, Thomas PV, McMahan K, Jacob-Dolan C, Liu J, He X, Hope D, Martinez EJ, Chen WH, Sciacca M, Hachmann NP, Lifton M, Miller J, Powers OC, Hall K, Wu C, Barrett J, Swafford I, Currier JR, King J, Corbitt C, Chang WC, Golub E, Rees PA, Peterson CE, Hajduczki A, Hussin E, Lange C, Gong H, Matyas GR, Rao M, Paquin-Proulx D, Gromowski GD, Lewis MG, Andersen H, Davis-Gardner M, Suthar MS, Michael NL, Bolton DL, Joyce MG, Modjarrad K, Barouch DH
- Issue date: 2022 Nov 25
- Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice.
- Authors: Mahrokhian SH, Tostanoski LH, Jacob-Dolan C, Zahn RC, Wegmann F, McMahan K, Yu J, Gebre MS, Bondzie EA, Wan H, Powers O, Ye T, Barrett J, Schuitemaker H, Barouch DH
- Issue date: 2022 Feb 23